Insecticides India Ltd Valuation Shifts to Fair Amidst Sector Comparisons

Valuation Metrics and Recent Changes

As of 1 June 2026, Insecticides India Ltd trades at a P/E ratio of 15.24, a figure that has contributed to its revised valuation grade from attractive to fair. This P/E multiple, while moderate, is significantly lower than several of its industry peers, indicating a more conservative market pricing. The company’s price-to-book value stands at 1.77, which also supports the fair valuation stance, reflecting a moderate premium over its net asset value.

Other valuation multiples include an EV to EBIT of 12.19 and EV to EBITDA of 10.29, both suggesting reasonable operational earnings coverage relative to enterprise value. The EV to capital employed ratio is 1.65, and EV to sales is 1.09, further underscoring a balanced valuation framework. The PEG ratio remains at 0.00, indicating either a lack of meaningful earnings growth projections or data unavailability for this metric.

Peer Comparison Highlights

When benchmarked against key competitors in the pesticides and agrochemicals sector, Insecticides India Ltd’s valuation appears more conservative. For instance, Bayer CropScience trades at a P/E of 29.83 and EV/EBITDA of 22.84, categorised as expensive. Anupam Rasayan and Bhagiradha Chemicals are classified as very expensive, with P/E ratios of 85.62 and 176.13 respectively, and EV/EBITDA multiples well above 30 and 59.

Conversely, peers such as Sharda Cropchem and Bharat Rasayan maintain very attractive valuations, with P/E ratios of 12.01 and 15.18 respectively, and EV/EBITDA multiples below 11. Dhanuka Agritech and BASF India also fall into the attractive category, with P/E ratios of 17.16 and 35.63, and EV/EBITDA multiples of 12.11 and 21.32 respectively.

This spectrum of valuations highlights that while Insecticides India Ltd is no longer considered a bargain, it remains competitively priced relative to the broader sector, especially when compared to the more richly valued large caps.

Financial Performance and Returns Contextualised

Insecticides India Ltd’s latest return on capital employed (ROCE) stands at 14.28%, while return on equity (ROE) is 12.34%. These figures indicate a solid operational efficiency and shareholder return profile, albeit not exceptional within the sector. The dividend yield is modest at 0.27%, reflecting a conservative payout policy.

Examining stock returns relative to the Sensex reveals a mixed performance. Over the past week, the stock declined by 2.21%, underperforming the Sensex’s 0.85% drop. However, over one month, the stock gained 5.22% while the Sensex fell by 3.51%. Year-to-date, Insecticides India Ltd has delivered a 2.59% return compared to the Sensex’s negative 12.26%, demonstrating relative resilience.

Longer-term returns are more favourable, with a three-year gain of 58.76% versus the Sensex’s 18.98%, and a five-year return of 108.81% compared to the benchmark’s 45.41%. Over a decade, the stock has appreciated 151.32%, slightly lagging the Sensex’s 180.55% rise. These figures suggest that while the stock has delivered strong absolute returns, it has occasionally lagged broader market gains.

Market Capitalisation and Recent Price Movements

Insecticides India Ltd is classified as a small-cap stock, with a current market price of ₹732.75, down 4.30% on the day from a previous close of ₹765.65. The stock’s 52-week high is ₹1,096.30, while the low is ₹525.90, indicating a wide trading range and potential volatility. Today’s intraday range has been between ₹724.25 and ₹763.35, reflecting some price consolidation near the lower end of recent levels.

The downgrade in the Mojo Grade from Hold to Sell on 25 May 2026, accompanied by a Mojo Score of 37.0, signals a cautious stance from the rating agency. This change is consistent with the shift in valuation grade from attractive to fair, suggesting that the stock’s price appreciation potential may be limited in the near term without a catalyst for re-rating.

Implications for Investors

The transition from an attractive to a fair valuation grade for Insecticides India Ltd suggests that the stock’s price attractiveness has moderated. Investors should weigh the company’s solid fundamentals and reasonable valuation against the backdrop of more compelling opportunities within the sector. The relatively low P/E ratio compared to expensive peers may offer some margin of safety, but the downgrade in rating and modest dividend yield temper enthusiasm.

Given the stock’s small-cap status and recent price volatility, risk-averse investors might prefer to monitor developments closely before committing fresh capital. Meanwhile, those with a higher risk tolerance could consider the stock’s long-term return track record and operational metrics as a basis for selective accumulation, particularly if the valuation stabilises or improves.

Comparative analysis indicates that stocks such as Sharda Cropchem, Bharat Rasayan, and Dhanuka Agritech present more attractive valuation opportunities, combining lower P/E multiples with robust EV/EBITDA ratios. These peers may warrant closer attention for portfolio diversification within the pesticides and agrochemicals sector.

Conclusion

Insecticides India Ltd’s valuation adjustment to a fair grade reflects a recalibration in market perception amid evolving sector dynamics and peer valuations. While the stock remains reasonably priced relative to many expensive competitors, the downgrade in rating and modest financial metrics suggest a cautious outlook. Investors should consider the broader sector landscape and alternative opportunities when evaluating this stock for their portfolios.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today